Pregnant Woman G1P0A0 with Severe Preeclampsia: A Case Report

Authors

  • Muhammad Rayza Rahmatullah Universitas Lampung
  • Ratna Dewi Puspitasari Universitas Lampung

DOI:

https://doi.org/10.53089/medula.v17i1.1994

Keywords:

Cesarean section, primigravida, severe preeclampsia

Abstract

Severe preeclampsia is a pregnancy complication that contributes to increased maternal and perinatal morbidity and mortality. Accurate diagnosis and management are essential to prevent more serious complications. This case report aims to describe the clinical manifestations, risk factors, management, and outcomes of a patient with severe preeclampsia. A 29-year-old woman, G1P0A0, at 39 weeks of gestation, presented with uterine contractions and blood-tinged mucous discharge. The patient had a history of elevated blood pressure since 32 weeks of gestation. Physical examination revealed a blood pressure of 152/112 mmHg, while urinalysis demonstrated positive proteinuria. Laboratory findings showed hemoglobin 13.9 g/dL, leukocytes 12,900/µL, and platelets 228,000/µL. Ultrasonography revealed a single live fetus in cephalic presentation with an estimated fetal weight of 3,302 grams. The patient was diagnosed as G1P0A0 at 39 weeks of gestation, in active phase of the first stage of labor, with severe preeclampsia. She received magnesium sulfate as seizure prophylaxis and nifedipine as an antihypertensive agent. During observation, fetal distress was identified, necessitating pregnancy termination via cesarean section. The infant was born weighing 3,200 grams with Apgar scores of 8/9. The mother's postoperative condition was stable, with blood pressure decreasing to 116/83 mmHg. This case demonstrates that severe preeclampsia may present without characteristic symptoms. Early detection, close monitoring, and appropriate management play a crucial role in achieving favorable maternal and neonatal outcomes.

Author Biography

Muhammad Rayza Rahmatullah, Universitas Lampung

 

 

References

Benardout M, Le Gresley A, ElShaer A, Wren SP. Preeclampsia: causes, consequences and the future. Obstet Gynaecol. 2022;24(1):5–15. doi: 10.1111/tog.12764.

Magee LA, Nicolaides KH, von Dadelszen P. Preeclampsia. N Engl J Med. 2022;386(19):1817–32. doi: 10.1056/NEJMra2109523.

Cunningham FG, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM. Williams Obstetrics. 26th ed. New York: McGraw-Hill Education; 2022. Chapter 40, Hypertensive Disorders; p. 710–54.

Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387(10022):999–1011. doi: 10.1016/S0140-6736(15)00070-7.

Kementerian Kesehatan Republik Indonesia. Peringatan Hari Preeklampsia Sedunia 2021. Jakarta: Kemenkes RI; 2021.

Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:481095. doi: 10.1155/2011/481095.

Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/91/2017 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Komplikasi Kehamilan. Jakarta: Kemenkes RI; 2017.

Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094–112. doi: 10.1161/CIRCRESAHA.118.313276.

Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275–89. doi: 10.1038/s41581-019-0119-6.

Kusmardika DA, Puspitasari RD. Preeklampsia berat dengan HELLP sindrom dan IUFD: sebuah laporan kasus. Medula. 2022;12(2):113–7. doi: 10.53089/medula.v12i2.437.

Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009;9:8. doi: 10.1186/1471-2393-9-8.

Padda IS, Tadi P. Magnesium sulfate. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 [diakses 13 Juni 2026]. Tersedia dari: https://www.ncbi.nlm.nih.gov/books/NBK554692/

Teran E, Escudero C, Vivero S, Molina G, Calle A. Obesity and preeclampsia: common pathophysiological mechanisms. Front Physiol. 2018;9:1838. doi: 10.3389/fphys.2018.01838.

Savira M, Novri DA, Hamidy Y, Donel S. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial. F1000Res. 2023;11:1287. doi: 10.12688/f1000research.125944.2.

Hauspurg A, Jeyabalan A. Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2022;226(2S):S1211–21. doi: 10.1016/j.ajog.2020.10.027.

Published

2026-06-25

How to Cite

Rahmatullah, M. R., & Puspitasari, R. D. (2026). Pregnant Woman G1P0A0 with Severe Preeclampsia: A Case Report. Medical Profession Journal of Lampung, 17(1), 116-123. https://doi.org/10.53089/medula.v17i1.1994

Issue

Section

Artikel